PFPT
LGND icon

Pinnacle Financial Partners (Tennessee)’s Ligand Pharmaceuticals LGND Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,613
Closed -$205K – 259
2016
Q3 		$205K Hold
2,613
– – 0.05% 261
2016
Q2 		$205K Buy
+2,613
New +$194K 0.05% 251

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s LGND Position: Q4 2016 in Review

Pinnacle Financial Partners (Tennessee) sold out of Ligand Pharmaceuticals (LGND) in Q4 2016, closing a stake of 2,613 shares — an estimated $205K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in LGND in Q2 2016 and held it in 2 quarters. The position peaked at $205K in Q3 2016. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Ligand Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 2,613 Ligand Pharmaceuticals shares in Q4 2016, an estimated $205K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Ligand Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Ligand Pharmaceuticals position peaked at $205K in Q3 2016.
  • 270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2016, filed 15 Feb 2017.